Results 11 to 20 of about 223,805 (315)
Background Peritoneal carcinomatosis is a fatal clinical presentation of colon cancer, characterized by unresponsiveness to conventional anticancer therapies, including immune checkpoint inhibitors.
Jeong Hun Kim+11 more
doaj +2 more sources
Peritoneal carcinomatosis [PDF]
Several gastrointestinal and gynecological malignancies have the potential to disseminate and grow in the peritoneal cavity. The occurrence of peritoneal carcinomatosis (PC) has been shown to significantly decrease overall survival in patients with liver
Ansaloni L+10 more
core +6 more sources
Background To review the available clinical data about the value of Indocyanine Green (ICG) fluorescence imaging for intraoperative detection of peritoneal carcinomatosis.
Gian Luca Baiocchi+5 more
doaj +2 more sources
Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer [PDF]
Patients with advanced ovarian cancer develop recurrence despite initial treatment response to standard treatment of surgery and intravenous/intraperitoneal (IP) chemotherapy, partly due to a limited peritoneal exposure time of chemotherapeutics ...
Ceelen, Wim+7 more
core +3 more sources
Advances in the management of peritoneal carcinomatosis. [PDF]
Eng OS, Blakely AM.
europepmc +3 more sources
An Unusual Case of Peritoneal Carcinomatosis [PDF]
The peritoneal surface remains an important failure site for patients with gastrointestinal and gynecologic malignancies. In the past, oncologists regarded peritoneal carcinomatosis as an incurable component of an intra-abdominal malignancy.
Stijn Hillewaere+2 more
doaj +3 more sources
Diagnosis and treatment of peritoneal carcinomatosis - a comprehensive overview. [PDF]
Peritoneal carcinomatosis, which is the most common malignant process of the peritoneal cavity, originates mostly from colorectal, gastric, and gynaecological malignancies.
Szadkowska MA+2 more
europepmc +2 more sources
PURPOSE After risk-reducing salpingo-oophorectomy (RRSO), BRCA1/2 pathogenic variant (PV) carriers have a residual risk to develop peritoneal carcinomatosis (PC). The etiology of PC is not yet clarified, but may be related to serous tubal intraepithelial
M. Steenbeek+21 more
semanticscholar +1 more source
Tuberculous peritonitis masquerading as carcinomatosis [PDF]
AbstractTuberculous peritonitis may debut with unspecific symptoms that can pose a diagnostic challenge for clinicians. We present a patient with tuberculous peritonitis masquerading as carcinomatosis. High clinical suspicion, appropriate identification of bacterial isolates of the Mycobacterium tuberculosis complex, and susceptibility testing are ...
Gabriel Motoa, Salvador Alvarez
openaire +3 more sources
Background The extent of peritoneal carcinomatosis is difficult to estimate preoperatively, but a valid measure would be important in identifying operable patients .
B. Jónsdóttir+6 more
semanticscholar +1 more source